All of the educational products youve come to know and trust - School Specialty, Inc. - Overview
OVERVIEW
INVESTOR.SCHOOLSPECIALTY.COM RANKINGS
Date Range
Date Range
Date Range
LINKS TO BUSINESS
WHAT DOES INVESTOR.SCHOOLSPECIALTY.COM LOOK LIKE?
INVESTOR.SCHOOLSPECIALTY.COM HOST
BOOKMARK ICON
TITLE
All of the educational products youve come to know and trust - School Specialty, Inc. - OverviewDESCRIPTION
Your descriptionCONTENT
This domain investor.schoolspecialty.com states the following, "Certificate of Incorporation DE-SSI Merger Sub Inc." Our analyzers observed that the website said " Amended and Restated Certificate of Incorporation of SSI Merger Sub Inc." The Website also stated " School Specialty Announces the Election of New Independent Board Members. School Specialtys Classroom DirectR Outfits New York Citys North Side School With Innovative, Collaborative Learning Furniture. School Specialty Announces Its Fiscal 2015 Fourth Quarter and Year-End Results. There are currently no events scheduled." The website's header had Your keywords as the most important keyword.OTHER DOMAINS
The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th.
Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes. To join the conversation, please visit the SciQuest Blog.
Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 04, 2015. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Click here to add this event to your calendar. ScottsMiracle-Gro Announces Third Quarter Results; Re-Affirms Full-Year Earnings Outlook. The Scotts Miracle-Gro Company Increases Quarterly Dividend Payment.
Listed holdings where we are lead owner. Long ownership horizon and value creation from dividends, value appreciation and cash flow. Our wholly-owned subsidiaries, partner-owned investments and other investments. We have a long-term perspective for all investments. We always act in the best interest of our portfolio companies by fully supporting them in their efforts to create sustainable value.
Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. Seattle Genetics Reports Second Quarter 2015 Financial Results.